1. Home
  2. PFLT vs CADL Comparison

PFLT vs CADL Comparison

Compare PFLT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennantPark Floating Rate Capital Ltd.

PFLT

PennantPark Floating Rate Capital Ltd.

HOLD

Current Price

$8.37

Market Cap

805.6M

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$4.91

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFLT
CADL
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
805.6M
357.4M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
PFLT
CADL
Price
$8.37
$4.91
Analyst Decision
Buy
Strong Buy
Analyst Count
6
8
Target Price
$10.67
$19.00
AVG Volume (30 Days)
960.9K
1.2M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
14.70%
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
$8.16
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.68
$4.34
52 Week High
$10.88
$7.24

Technical Indicators

Market Signals
Indicator
PFLT
CADL
Relative Strength Index (RSI) 55.27 46.89
Support Level $7.92 $4.56
Resistance Level $9.46 $5.42
Average True Range (ATR) 0.23 0.24
MACD 0.07 0.03
Stochastic Oscillator 76.06 60.78

Price Performance

Historical Comparison
PFLT
CADL

About PFLT PennantPark Floating Rate Capital Ltd.

PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate both current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generates revenue in the form of interest income on the debt securities and dividends.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: